GAM SYSTEMATIC LLP - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 139 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2016. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
GAM SYSTEMATIC LLP ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2016$179,000,000
+5866.7%
15,180
+9212.9%
0.04%
+3700.0%
Q1 2016$3,000,000
-96.3%
163
-94.2%
0.00%
-95.7%
Q4 2015$81,000,000
+710.0%
2,815
+737.8%
0.02%
+1050.0%
Q3 2015$10,000,0003360.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q1 2016
NameSharesValueWeighting ↓
ADVANTAGE INVESTMENT MANAGEMENT, LLC 105$00.00%
Sterling Investment Advisors, Ltd. 250$00.00%
Front Row Advisors LLC 60$00.00%
Executive Wealth Management, LLC 20$00.00%
BARCLAYS PLC 1,300$00.00%
BARCLAYS PLC 33,172$10,0000.00%
HUNTINGTON NATIONAL BANK 1$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Financial Gravity Asset Management, Inc. 50$00.00%
Vectors Research Management, LLC 505$00.00%
View complete list of INSYS THERAPEUTICS INC NEW shareholders